Patent details

EP2219619 Title: DISULFIDE CHEMOTHERAPEUTIC AGENTS AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP2219619
PCT Application Number:
US2008083994
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088524921
PCT Publication Number:
WO2009067489
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DISULFIDE CHEMOTHERAPEUTIC AGENTS AND METHODS OF USE THEREOF
French Title of Invention:
AGENTS CHIMIOTHÉRAPEUTIQUES À BASE DE DISULFURE ET PROCÉDÉS POUR LES UTILISER
German Title of Invention:
DISULFID-CHEMOTHERAPEUTIKA UND ANWENDUNGSVERFAHREN DAFÜR
SPC Number:

Dates

Filing date:
19/11/2008
Grant date:
15/07/2020
EP Publication Date:
25/08/2010
PCT Publication Date:
28/05/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/07/2020
EP B1 Publication Date:
15/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/11/2020
Expiration date:
19/11/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/07/2020
 
 

Name:
Lankenau Institute for Medical Research
Address:
100 East Lancaster Avenue, Wynnewood, PA 19096, United States (US)

Inventor

1

Name:
AYENE, Iraimoudi, S.
Address:
United States (US)

2

Name:
PRENDERGAST, George C.
Address:
United States (US)

Priority

Priority Number:
989383 P
Priority Date:
20/11/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 31/10; A61K 31/194; A61K 31/198; A61K 31/7048; A61K 45/06; A61K 33/24;

Publication

European Patent Bulletin

Issue number:
202029
Publication date:
15/07/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages